Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro
Open Access
- 1 January 2017
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2017, 1-12
Abstract
Interferon-α(IFN-α) has been used for more than 20 years as the first-line therapy for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, because it has a number of antiviral effects. In this study, we describe a novel mode of its antiviral action. We demonstrate that the supernatant from IFN-α-treated cultured cells restricted HBV and HCV infection by inhibiting viral entry into hepatoma cells. The factors contained in the supernatant competed with the virus for binding to heparan glycosaminoglycans—the nonspecific attachment step shared by HBV and HCV. Secreted factors of high molecular mass that bind to heparin columns elicited the antiviral effect. In conclusion, IFN-αis able to induce soluble factors that can bind to heparan glycosaminoglycans thus leading to the inhibition of viral binding.Keywords
Funding Information
- German Center for Infection Research (HVF-045)
- Helmholtz validation fond (HVF-045)
- International Liver Cancer Association (HVF-045)
This publication has 53 references indexed in Scilit:
- A New Class of Synthetic Peptide Inhibitors Blocks Attachment and Entry of Human Pathogenic VirusesThe Journal of Infectious Diseases, 2012
- The IFITM Proteins Inhibit HIV-1 InfectionJournal of Virology, 2011
- Interferon-Induced Cell Membrane Proteins, IFITM3 and Tetherin, Inhibit Vesicular Stomatitis Virus Infection via Distinct MechanismsJournal of Virology, 2010
- Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B VirusJournal of Virology, 2010
- The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue VirusCell, 2009
- Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNANature, 2008
- Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C VirusJournal of Virology, 2008
- Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycansHepatology, 2007
- Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter VirusesJournal of Virology, 2006
- Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimerasProceedings of the National Academy of Sciences, 2006